Olympus Takes Stake in Dutch Startup PamGene; Cos to Jointly Develop Microarrays | GenomeWeb

NEW YORK, March 14 - PamGene, a Dutch microarray startup, and Olympus Optical have agreed to jointly develop a platform for manufacturing and analyzing DNA microarrays, the companies said Wednesday.

As part of the alliance, Olympus has made a "significant" equity investment in PamGene, based in Den Bosch, the Netherlands. Exact financial details were not disclosed. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.